Dr. Rabeena Fazal, MD

Dr. Fazal practices at Rf Medical Practice in South Ozone Park, New York.

Dr. Fazal's NPI, 1750394391, was assigned on August 14, 2006. Dr. Fazal graduated from Icahn School Of Medicine At Mount Sinai in 2002. Dr. Fazal holds New York license 237316.

Dr. Fazal's primary practice is Rf Medical Practice, at 134-5 Rockaway Blvd, South Ozone Park, NY 11420 in Queens County. The practice phone is (718) 323-9700.

Dr. Fazal's primary practice is Rf Medical Practice in South Ozone Park, New York. The medical group on file is MedCare Consultants. Dmand AI also links Dr. Fazal to 1 more physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fazal practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Fazal's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Fazal is board certified in internal medicine by the American Board of Internal Medicine. Dr. Fazal is licensed in New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances and kidney cysts among the conditions Dr. Fazal treats.

CMS data shows 238 Medicare services from Dr. Fazal across 5 procedure codes in 2024, for 79 Medicare patients. Medicare paid $21,395 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Fazal in 2024. The largest group is 65 to 74, with 32 patients. 75% of them have diabetes, and 75% have high blood pressure. 47% are also on Medicaid. Their average risk score is 1.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Fazal's median patient age at 68, with 44% women.

In 2024, Dr. Fazal wrote 983 Medicare Part D claims for 223 patients. 67% of them were for generic drugs. CMS names the drug for 728 of them, across 22 drugs with 11 or more claims each, at $252,287 in total drug cost. In 2023, CMS named 439 claims across 19 drugs.

Dr. Fazal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fazal as offering telehealth.

CMS Open Payments shows 3 general payments to Dr. Fazal from 3 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Travere Therapeutics, Inc. paid the most, $125.

Dr. Fazal graduated from Icahn School Of Medicine At Mount Sinai in 2002.

Dr. Fazal is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.